Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IL-18 derived from microwave-ablated osteosarcoma facilitates antitumor response.

Journal for immunotherapy of cancer·2026
Same author

Design and Synthesis of a Novel Covalent Dihydropteridinone Derivative as a Highly Potent and Orally Bioavailable PLK1 Inhibitor for the Treatment of Chronic Myeloid Leukemia.

Journal of medicinal chemistry·2026
Same author

Synthesis of Novel Isoxazoline Derivatives with Selective Inhibition of the Drug Efflux Pump Mdr1 to Reverse Drug Resistance of <i>Candida albicans</i> <i>In Vitro</i> and <i>In Vivo</i>.

Journal of medicinal chemistry·2026
Same author

Pyridoimidazolyl Sulfonamide Compound <b>2</b>: A Superior Dual-Acting Drug Candidate with Potent URAT1 Inhibition and Anti-Inflammatory Activity for Gout Management.

Journal of medicinal chemistry·2026
Same author

A heterozygous deletion and inversion at the NHEJ1‑IHH locus associated with shank length in Yunlong short-leg chicken.

BMC genomics·2026
Same author

ASCL2-mediated macrophage-myofibroblast transition generates immunosuppressive CAF_7 in NSCLC bone metastases.

Journal of experimental & clinical cancer research : CR·2026
Same journal

PSDTA: An Approach to Drug-Target Binding Affinity Prediction by Integrating Physicochemical and Structural Information to Reduce Feature Redundancy.

Journal of chemical information and modeling·2026
Same journal

M-JEPA: Predictive Self-Supervised Learning for Molecular Graphs with Scaffold-Shift Evaluation on Tox21.

Journal of chemical information and modeling·2026
Same journal

Advancing Biochemical Molecule Registration, Representation and Search for New Drug Modalities.

Journal of chemical information and modeling·2026
Same journal

A Unified Molecular Graph and Protein Language Model Framework for Predicting Human Drug-Hormone Receptor Interactions with Structure-Aware Validation.

Journal of chemical information and modeling·2026
Same journal

Intricate Role of Cholesterol in Membrane Fusion.

Journal of chemical information and modeling·2026
Same journal

tmGNN-XAI: An Explainable Graph Neural Network Tool for Predicting Electronic Properties of Transition Metal Complexes from SMILES.

Journal of chemical information and modeling·2026
See all related articles

Related Experiment Video

Updated: Nov 24, 2025

Author Spotlight: Development of a Scaffold-Free Acoustic Assembly Method for High-Quality 3D Cell Spheroid Culture
05:17

Author Spotlight: Development of a Scaffold-Free Acoustic Assembly Method for High-Quality 3D Cell Spheroid Culture

Published on: October 13, 2023

1.4K

AIScaffold: A Web-Based Tool for Scaffold Diversification Using Deep Learning.

Junyong Lai1, Xiangbin Li2, Yanxing Wang1

  • 1State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, 100191 Beijing, P. R. China.

Journal of Chemical Information and Modeling
|December 28, 2020
PubMed
Summary
This summary is machine-generated.

AIScaffold is a new web tool that uses deep learning for molecular scaffold diversification. It rapidly generates thousands of novel drug-like molecules to accelerate lead compound optimization in drug design.

More Related Videos

Electrospinning Growth Factor Releasing Microspheres into Fibrous Scaffolds
09:29

Electrospinning Growth Factor Releasing Microspheres into Fibrous Scaffolds

Published on: August 16, 2014

12.5K
A Net Mold-based Method of Scaffold-free Three-Dimensional Cardiac Tissue Creation
06:57

A Net Mold-based Method of Scaffold-free Three-Dimensional Cardiac Tissue Creation

Published on: August 5, 2018

9.2K

Related Experiment Videos

Last Updated: Nov 24, 2025

Author Spotlight: Development of a Scaffold-Free Acoustic Assembly Method for High-Quality 3D Cell Spheroid Culture
05:17

Author Spotlight: Development of a Scaffold-Free Acoustic Assembly Method for High-Quality 3D Cell Spheroid Culture

Published on: October 13, 2023

1.4K
Electrospinning Growth Factor Releasing Microspheres into Fibrous Scaffolds
09:29

Electrospinning Growth Factor Releasing Microspheres into Fibrous Scaffolds

Published on: August 16, 2014

12.5K
A Net Mold-based Method of Scaffold-free Three-Dimensional Cardiac Tissue Creation
06:57

A Net Mold-based Method of Scaffold-free Three-Dimensional Cardiac Tissue Creation

Published on: August 5, 2018

9.2K

Area of Science:

  • Medicinal Chemistry
  • Computational Drug Design
  • Artificial Intelligence in Drug Discovery

Background:

  • Molecular scaffolds are fundamental building blocks in drug design.
  • Existing tools for scaffold diversification are limited, hindering medicinal chemists' workflow.
  • Efficient scaffold diversification is crucial for lead compound optimization.

Purpose of the Study:

  • To introduce AIScaffold, a novel web-based tool for rapid scaffold diversification.
  • To leverage deep generative models for large-scale molecule generation.
  • To provide medicinal chemists with an efficient tool to accelerate drug design.

Main Methods:

  • Development of AIScaffold, a web platform utilizing deep generative models.
  • Implementation of large-scale molecular diversification (up to 500,000 molecules).
  • Inclusion of site-specific diversification features.

Main Results:

  • AIScaffold performs large-scale diversification in minutes.
  • The tool recommends the top 500 (0.1%) diversified molecules.
  • Site-specific diversification capabilities are supported.

Conclusions:

  • AIScaffold significantly facilitates the scaffold diversification process.
  • The tool accelerates drug design by providing novel molecular candidates.
  • AIScaffold addresses the current lack of specialized tools for scaffold diversification.